Mediastinal lymphadenopathy is the swelling of the lymph nodes in the chest cavity. It is a symptom of various conditions and can be benign or malignant. Mediastinal lymphadenopathy is a condition ...

Background: This study aims to introduce an optimized method named "non-grasping en bloc mediastinal lymph node dissection (MLND)" through video-assisted thoracoscopic surgery (VATS). Methods: Between ...

Please provide your email address to receive an email when new articles are posted on . “The standard treatment procedure for resectable non-small cell lung cancer involves lobectomy with systemic ...

Mediastinal staging of non-small-cell lung cancer (NSCLC) is of paramount importance. It distinguishes operable from inoperable disease, guides prognosis and allows accurate comparison of outcomes in ...

Systematic mediastinal lymph node dissection (LND) or sampling is currently recommended for patients with early-stage non–small cell lung cancer. We aimed to investigate whether no mediastinal LND was ...

In a trial, selected patients with early non-small cell lung cancer did not benefit from mediastinal lymph node dissection (LND). Mediastinal LND resulted in longer surgeries, increased bleeding, and ...

Usually, swollen chest lymph nodes are too deep in the chest for a person to feel them. Any swollen lymph nodes in the chest appear on imaging scans. Swelling can indicate an underlying condition.

Theoretically, the introduction of gas as a contrast material into the various soft-tissue planes of the mediastinum, pneumomediastinography, should be the ideal radiologic technic for outlining ...

Evaluation of the hilar and mediastinal lymph nodes is part of the surgical treatment of non-small cell lung cancer (NSCLC). It is also vital to the staging of lung cancer, which determines the need ...

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research ...

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study We conducted a multicenter, open-label, ...